3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
28
Prostatic Neoplasms
14
Neoplasm Metastasis
12
Osteoporosis
8
Multiple Myeloma
8
Pain
7
Lung Neoplasms
4
Fractures, Bone
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasms, Plasma Cell
3
Humoral Hypercalcemia Of Malignancy
3
Bone Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Neoplasms
2
Lymphoma
2
Hematologic Neoplasms
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Paraproteinemias
1
Osteosarcoma
1
Neoplastic Processes
1
Lymphoma, Non-Hodgkin
1
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
1
Hematologic Diseases
1
Giant Cell Tumor of Bone
1
Disease Progression
1
Interventions
Vincristine
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
Busulfan
2
treosulfan
1
ganitumab
1
etoposide phosphate
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Temozolomide
1
Radiosurgery
1
Radiation
1
Melphalan
1
Irinotecan
1
FANG vaccine
1
Diphosphonates
1
Dactinomycin
1
Cyproheptadine
1
Congresses as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma, Ewing
×
Zoledronic Acid
×
Clear all
NCT00987636
2019-10-22
EWING2008
University Hospital Muenster
Phase 3
Completed
907 enrolled